All studies
Not yet recruitingOBSERVATIONAL

Evaluation of Heart Failure Telemonitoring Eligibility Criteria

This study focuses on people in France who have heart failure and were previously enrolled in a home monitoring programme called CARDIAUVERGNE. This programme helps keep an eye on patients to try and stop them from needing to go back into hospital. Patients left the programme if they no longer met certain health criteria set by French health authorities. The study aims to understand what happened to these patients and how their health changed after they were no longer being monitored daily. Researchers are looking at their medical notes from when they joined, when they left, and one year later. They will also have a short phone call with patients a year after they leave the programme to check how they are feeling and what treatments they are on.

At a glance

Status
Not yet recruiting
Sponsor
University Hospital, Clermont-Ferrand
Enrolment target
130
Start
01 Dec 2025
Estimated completion
01 Dec 2026

What is this study about?

Heart failure is a condition where your heart isn't pumping blood around your body as well as it should. This can lead to symptoms like breathlessness and swelling. To help people manage their condition and avoid emergency hospital stays, some hospitals offer home monitoring programmes. These programmes often involve daily checks, like weighing yourself on special scales, which helps a team of nurses keep a close eye on your health.

This particular study is looking back at how people with heart failure, who were part of a home monitoring programme in a French hospital, fared after they left the programme. Patients were part of the programme because they either had a heart failure episode recently or were struggling with breathlessness and had certain blood test results. They left the programme if they no longer met these specific health targets.

The main goal of this research is to find out if patients who no longer met the monitoring criteria actually had a low risk of their health getting worse. By understanding this, doctors can learn whether the current rules for who should be in these programmes are right, and how best to support people after they leave such monitoring.

Key takeaways

  • This study looks at heart failure patients who previously left a home monitoring programme.
  • It aims to understand if patients who no longer met certain health criteria had good health outcomes.
  • No new treatments or hospital visits are required for participants.
  • Information is collected from existing medical records and a short phone call.
  • Findings could help improve future heart failure monitoring programmes.

Who may be eligible?

To be part of this study, you would be an adult who was previously in the CARDIAUVERGNE home monitoring programme for heart failure at Clermont-Ferrand’s hospital in France. You would have been enrolled between January 2023 and December 2024 because you met specific criteria, like having had a heart failure episode in the last year or experiencing breathlessness with certain blood test results. Importantly, you must have left the programme because a doctor decided you no longer met these specific health criteria.

You would not be able to be in this study if you left the monitoring programme for other reasons. This includes if you chose to leave, sadly passed away, moved to a different area, or if there was another medical reason not related to the health authority's criteria for leaving, or if you struggled to keep up with the monitoring.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you an adult aged 18 or over?
  2. Were you in the CARDIAUVERGNE heart failure home monitoring programme at Clermont-Ferrand’s hospital between Jan 2023 and Dec 2024?
  3. Did you leave the programme because a doctor said you no longer met the health authority's specific criteria?
  4. Did you *not* leave the programme for other reasons like moving house or personal choice?
Answer every question to see your result.

What does participation involve?

If you were part of this study, you wouldn't need to do anything new. The researchers are simply looking back at information already in your medical records from three different points in time: when you first joined the monitoring programme, when you left it, and one year after you left. About a year after you left the programme, a member of the research team would give you a short phone call. This call would be to check how you've been doing since leaving, ask about any symptoms you might have, and note down any treatments you are currently on. The total duration of your involvement is simply observing your health journey over that time.

Potential risks and benefits

Since this study only looks at your existing medical records and involves a short phone call, there are no physical risks involved. The main benefit is that your information will help doctors understand more about heart failure home monitoring programmes, potentially leading to better care for other patients in the future. You have the right to withdraw your consent for your data to be used at any time, even after the study has started, without it affecting your medical care.

Locations (1)

  • CHU Clermont-Ferrand
    Verified postcode
    Clermont-Ferrand, France

Common questions

What is 'heart failure telemonitoring'?

It's a way for doctors and nurses to keep an eye on your heart failure from your home, often using special equipment like scales, to help manage your condition.

Why is this study being done?

The study wants to see how people with heart failure get on after they stop home monitoring, to check if the current rules for who leaves the programme are correct.

Do I need to take any new medicine or visit the hospital?

No, if you're part of this study, you won't take new medicine or visit the hospital for the study. It only uses past medical information and a quick phone call.

What is NYHA2 and NT-proBNP?

These are medical terms used by doctors to describe how severe your heart failure symptoms are (NYHA2) and to measure a substance in your blood that tells them about your heart's health (NT-proBNP).

Can I choose not to be in the study if I was eligible?

Yes, you always have the right to say no to being part of a study, or to withdraw your information if you change your mind later.

How to find out more

Lise Laclautre

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Evaluation of Heart Failure Telemonitoring Eligibility Crite…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.